Home
Our Science
Overview
PHP-303
Antibody Drug Conjugates
Pipeline
Team
Careers
Investors
Contact
Company Info
Posters & Publications
Investors
Company Information
Contact Information
Presentations
Posters & Publications
Peak Bio, Inc. Presents Preclinical Data Highlighting Potential of Differentiated Trop2 ADC at the 2023 AACR Annual Meeting
April 19, 2023
Download Poster
Peak Bio, Inc introduces a novel immunostimulatory ADC payload targeting RNA splicing and demonstrates tumoricidal properties of a proof-of concept Her2 ADC at the 2021 AACR annual meeting
April 10, 2021
Download Poster